Literature DB >> 19548834

Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.

Erin B Hedican1, Carlota Medus, John M Besser, Billie A Juni, Bonnie Koziol, Charlott Taylor, Kirk E Smith.   

Abstract

BACKGROUND: Escherichia coli O157:H7 (O157) is the Shiga toxin-producing E. coli (STEC) serotype most frequently isolated and most often associated with hemolytic uremic syndrome (HUS) in the United States. Non-O157 STEC serotypes can also cause serious illness, but their impact as pathogens remains undefined. We compared characteristics of non-O157 and O157 STEC infections identified through sentinel surveillance.
METHODS: Sentinel sites included a metropolitan health maintenance organization laboratory and a hospital laboratory serving a small city and rural area. We received sorbitol-MacConkey agar plates from every stool culture performed at both sites during 2000-2006. Colony sweeps were screened for stx1 and stx2 by polymerase chain reaction. E. coli identity, serotype, and presence of stx1 and/or stx2 were confirmed on individual isolates.
RESULTS: Two hundred six STEC isolates were identified: 108 (52%) were non-O157 serotypes, and 98 (48%) were O157. Of non-O157 cases, 54% involved bloody diarrhea, and 8% involved hospitalization. Non-O157 isolates with at least stx2 were not more likely to cause severe illness (bloody diarrhea, hospitalization, or HUS) than were non-O157 isolates with only stx1. O157 cases were more likely than non-O157 cases to involve bloody diarrhea (78% vs 54%; P < .001), hospitalization (34% vs 8%; P < .001 and HUS (7% vs 0%; P = .005). When including only isolates with at least stx2, O157 cases were still more likely to involve bloody diarrhea (78% vs 56%; P = .02) and hospitalization (33% vs 12%; P = .01) than non-O157 cases.
CONCLUSIONS: Differences in severity among STEC infections could not be explained by stx2, suggesting that additional factors are important in STEC virulence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548834     DOI: 10.1086/600302

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

1.  A sensitive multiplex, real-time PCR assay for prospective detection of Shiga toxin-producing Escherichia coli from stool samples reveals similar incidences but variable severities of non-O157 and O157 infections in northern California.

Authors:  Martina I Lefterova; Kathleen A Slater; Indre Budvytiene; Patricia A Dadone; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2013-07-10       Impact factor: 5.948

Review 2.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

3.  Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center.

Authors:  Emilie Vallières; Maude Saint-Jean; Fabien Rallu
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

4.  Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection.

Authors:  Christina R Hermos; Marcie Janineh; Linda L Han; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  Comparison of clinical and epidemiological features of Shiga toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 2011.

Authors:  Xuetao Wang; Marsha Taylor; Linda Hoang; Judi Ekkert; Craig Nowakowski; Jason Stone; Greg Tone; Steven Trerise; Ana Paccagnella; Titus Wong; Eleni Galanis
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

6.  Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Authors:  Glenn Buvens; Yves De Gheldre; Anne Dediste; Anne-Isabelle de Moreau; Georges Mascart; Anne Simon; Daniël Allemeersch; Flemming Scheutz; Sabine Lauwers; Denis Piérard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.

Authors:  D J Stearns-Kurosawa; Valta Collins; Scott Freeman; Vernon L Tesh; Shinichiro Kurosawa
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

8.  Prevalence and relatedness of Escherichia coli O157:H7 strains in the feces and on the hides and carcasses of U.S. meat goats at slaughter.

Authors:  M E Jacob; D M Foster; A T Rogers; C C Balcomb; M W Sanderson
Journal:  Appl Environ Microbiol       Date:  2013-04-12       Impact factor: 4.792

Review 9.  HUS and TTP in Children.

Authors:  Howard Trachtman
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

10.  A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.

Authors:  Jacqueline M Tremblay; Jean Mukherjee; Clinton E Leysath; Michelle Debatis; Kwasi Ofori; Karen Baldwin; Courtney Boucher; Rachel Peters; Gillian Beamer; Abhineet Sheoran; Daniela Bedenice; Saul Tzipori; Charles B Shoemaker
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.